Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
about
Current treatment of atypical hemolytic uremic syndromeHaemolytic uraemic syndrome.Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome.CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.The Genetics of Ultra-Rare Renal Disease.Complement related kidney diseases: Recurrence after transplantation.Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.Kidney retransplantation in children following rejection and recurrent disease.Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneri.Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndrome.Management of hemolytic uremic syndromeHemolytic uremic syndromeUnexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy
P2860
Q27003211-AF8D46BB-F880-471C-9EFD-4F93EA964FC4Q30244707-0C550757-0592-4B7C-9313-3766AD7A41ECQ33425435-765475AE-6818-4440-AB07-B5E928BFD671Q33426147-58D40C90-5F5C-4A2C-B8F6-ECB9393427C6Q33426927-88933C3D-5195-4466-92D6-AE2453BA29E1Q33433038-FE08B2DA-88FC-4830-A38C-2B03981490D9Q37032691-F31E0AD0-763C-4C59-81B9-30FCB5295D28Q37522557-CB6C52C5-F079-41FF-9373-D764FCC2B7F3Q37547496-4D5DC80D-F053-4DB7-B392-1FE1FD9FF464Q38798905-F262518E-CA49-470F-9FF5-07AB951C43D8Q40052746-64A20B5E-F3FF-4C13-9D62-FDC5CFFD5887Q40075347-23C5E3E6-1C4E-41E6-9DF0-24417B5D4C4EQ42086661-A3EAF3E1-4145-4795-ABD2-B93639358A3CQ47321222-11E7A6AB-A73A-4BBF-9FAD-49B50F069557Q55077656-B870BE60-390C-4E52-B9A8-9692E9625FBFQ57161996-544FCBC8-BF3C-4CE5-AFDA-6AA025B773AAQ57701679-5794A495-371E-45F3-8C0D-5B8648609CF8Q58620408-6FE09D2A-3806-475B-B099-2B4A78B9FCB6
P2860
Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Two patients with history of S ...... and complement gene mutations.
@ast
Two patients with history of S ...... and complement gene mutations.
@en
type
label
Two patients with history of S ...... and complement gene mutations.
@ast
Two patients with history of S ...... and complement gene mutations.
@en
prefLabel
Two patients with history of S ...... and complement gene mutations.
@ast
Two patients with history of S ...... and complement gene mutations.
@en
P2093
P2860
P50
P356
P1476
Two patients with history of S ...... and complement gene mutations.
@en
P2093
P2860
P304
P356
10.1111/AJT.12297
P407
P577
2013-06-03T00:00:00Z